Ajanta Pharma Limited

Price Chart

Risk-Adjusted Performance

Ajanta Pharma Limited (AJANTPHARM) Price Performance

Ajanta Pharma Limited (AJANTPHARM) trades on NSE in INR. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at INR2790.20, down 1.32% from the previous close.

Over the past year, AJANTPHARM has traded between a low of INR2361.91 and a high of INR3119.50. The stock has gained 5.2% over this period. It is currently 10.6% below its 52-week high.

Ajanta Pharma Limited has a market capitalization of $353.44B, with a price-to-earnings ratio of 34.78 and a dividend yield of 0.97%.

About Ajanta Pharma Limited

Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic areas comprising cardiology, dermatology, ophthalmology, and pain management. The company operates in India, Africa, Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.